instruments were used to measure the phenotype, analysis of the skewed sum scores is therefore recommended. Moreover, statistical power of future genetic studies could further improve if researchers would use phenotypic instruments that resolve individual difference in cases as well as controls, that is, across the entire trait range.
Understanding the molecular mechanism of extreme or impaired decision-making observed in neuropsychiatric disorders, such as pathological gambling and attention-deficit hyperactivity disorder (ADHD), could contribute to better assessment and the development of novel pharmacological therapies for those disorders. Typically, most people show a disproportionate distaste for possible losses compared with equal-sized gains. This human in vivo molecular imaging study has demonstrated that individuals with lower thalamic norepinephrine transporters (NET) showed more exaggerated aversion to financial loss.
Empirical and field studies suggest that losses have greater impact than equivalent gains. 1 For example, a typical person would only accept a two-outcome gamble in which $50 could be lost if the possible gain is $100, twice as large. This greater sensitivity to losses than to gains is called 'loss aversion' and substantial individual differences in it have been observed in many behavioral studies. 1, 2 In psychiatric populations, pathological gambling showed diminished sensitivity to monetary loss itself and, more specifically, patients with ADHD and psychopaths showed reduced sensitivity to the magnitude of monetary loss. 3, 4 Recent functional magnetic resonance imaging and lesion studies have shown that the prefrontal cortex (PFC), striatum and amygdala are involved in loss aversion. 5, 6 However, little is known about modulatory neurotransmission in this phenomenon. There is circumstantial evidence that NE may be important for loss aversion. Central NE blockade by propranolol reduced sensitivity to the magnitude of possible losses from gambles. 7 A recent psychophysiological study demonstrated that arousal is associated with loss aversion. 8 We utilized positron emission tomography (PET) scans with (S,S)-[
18 F]FMeNER-D 2 to investigate the relationship between central NET and loss aversion. A NET-rich region available to PET imaging with this ligand is the thalamus. The amygdala and PFC are also innervated by NE, but relatively low expression of NET prevented reliable measurement of their NET binding in the current study. We expected that NET in the thalamus would mediate loss aversion.
In all, 19 healthy male volunteers participated in PET scans for quantification of NET in the brain. Brain radioactivities were measured with scanning from 0 to 90 min, followed by scanning from 120 to 180 min. The region-of-interest was set on the bilateral thalamus. NET binding in the thalamus was calculated by the area-under-the-curve ratio method using the PMOD software package (PMOD Technologies, Zurich, Switzerland). An integration interval of 120--180 min was used in this method because specific binding reaches a peak during this period of PET measurement (Supplementary Information). Loss aversion parameters were determined outside the PET scanner. Participants were presented mixed gambles that had a 50% chance of losing a fixed amount of X and a 50% chance of gaining Y. The amounts of possible gain Y to make up for a 50% chance of losing X were determined by a staircase procedure (Supplementary Information), yielding an estimate of loss aversion l from Y ¼ l Â X. A median of l was 3.01 (range: 0.98--9.98). Mean binding potential of (S,S)-[ 18 F]FMeNER-D 2 in the thalamus was 0.57 ± 0.10. There was a strong negative correlation between l and NET binding in the thalamus (Figure 1) .
Although NE has been implicated in arousal, recent studies also suggest that NE affects processing of salient information. 9 Neurons of the locus coeruleus (LC), the major source of NE in the brain, is phasically evoked by salient or emotional stimuli, and phasic LC activation also increases NE release in target sites. 9 Increasing NE tone by NE reuptake inhibitor improves detection of emotional stimuli, 10 and blockade of central NE by propranolol attenuates the sensitivity to the magnitude of possible losses. 7 A recent study showed that, on average, physiological arousal response to losses was greater than to equivalent gains. 8 This means that losses are more emotionally laden and salient than equivalent gains. The study also reported that individuals with greater arousal response to losses versus gains tend to be more loss aversive. 8 Thus, our finding suggests that individuals with low NET might show an enhanced effect of NE released by salient stimuli due to low re-uptake, and consequently show pronounced emotional or arousal response to losses relative to gains. Due to radioligand limitations, we could not test the amygdala and PFC, which are innervated by NE and implicated in loss aversion.
Letters to the Editor Thalamic NET might be an indirect mediator of the relationship between NE transmission and loss aversion. It stands to reason that careful interpretation is needed, and future investigation will be required. In any event, we believe that this novel finding could provide new perspectives on altered decision making observed in neuropsychiatric disorders. The midbrain dopamine system is implicated in mediating the reactivity of the organism to salient environmental stimuli, 1, 2 including emotional events, 3 at different timescales. 2 Preclinical and human neuroimaging studies implicate the dopamine system in coding stimulus salience 4 through its innervations of nigrostriatal and mesocorticolimbic pathways, 1,2 and dysfunction of this system has an important role in neuropsychiatric disorders such as schizophrenia and depression that are accompanied by impaired social and emotional cognition. However, the role of dopamine in modulating transient (in milliseconds) distributed neural representation of human emotional cognition remains undefined. We examined the relationship of midbrain presynaptic dopamine (directly measured with positron emission tomography (PET)) to 'sustained' and 'transient' neural responses to salient emotional facial expressions (measured with fMRI and magnetoencephalography (MEG), respectively).
A total of 21 healthy participants (mean age ¼ 31, six females) consented according to NIH-IRB and Radiation Safety Committee guidelines before undergoing 90 min PET scans following IV administration of 16-mCi[
18 F]fluoroDOPA (FDOPA). A cerebellar reference region was used to determine FDOPA-Ki, a reproducible measure of presynaptic DA stores and synthesis. 5 After coregistration of FDOPA scans onto native space MRIs, a manually-defined midbrain volume of interest within each individual's MRI was used for extraction of mean Ki values (Supplementary Information).
All 21 FDOPA-PET participants underwent event-related fMRI while viewing videos of 10 different actors portraying dynamic fearful, happy and neutral expressions. A total of 16 of the 21 Letters to the Editor
